Covered recipient · General Payments record
JAMES F ADAMS
Allopathic & Osteopathic Physicians Radiology Radiation Oncology
General Payments · PY2018–2024
$971.61
- Reported across 52 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $187.83 | 11 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| GlaxoSmithKline, LLC. | $170.87 | 10 |
| Incyte Corporation | $16.96 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (11)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| GlaxoSmithKline, LLC. | $21.47 | 01/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116644910 | CMS |
| GlaxoSmithKline, LLC. | $20.42 | 03/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116097949 | CMS |
| GlaxoSmithKline, LLC. | $20.29 | 04/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116069422 | CMS |
| GlaxoSmithKline, LLC. | $13.81 | 05/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116267944 | CMS |
| GlaxoSmithKline, LLC. | $10.98 | 06/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116024262 | CMS |
| GlaxoSmithKline, LLC. | $20.45 | 07/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116453109 | CMS |
| GlaxoSmithKline, LLC. | $15.52 | 08/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116302813 | CMS |
| GlaxoSmithKline, LLC. | $13.17 | 10/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116458643 | CMS |
| GlaxoSmithKline, LLC. | $21.92 | 12/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116401551 | CMS |
| GlaxoSmithKline, LLC. | $12.84 | 12/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116277750 | CMS |
| Incyte Corporation | $16.96 | 06/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141290006 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2020, 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.